ELLEPHASE
DEAD

Serial Number

98040354

Owner

Vanda Pharmaceuticals Inc.

Attorney

Jayme M. Torelli

Filing Date

Jun 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ELLEPHASE Trademark

Serial Number: 98040354

ELLEPHASE is a trademark filed by Vanda Pharmaceuticals Inc. on June 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Vanda Pharmaceuticals Inc. (104 trademarks)

Suite 300
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

June 13, 2023

Registration Date

Not Registered

Published for Opposition

December 19, 2023

Goods & Services

Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 17, 2024 ETOP
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Mar 15, 2024 MAB5
ABANDONMENT - AFTER PUBLICATION
Mar 15, 2024 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Mar 14, 2024 EXAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 8, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2023 CNSA
ASSIGNED TO EXAMINER
Nov 13, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2023 NWOS
NEW APPLICATION ENTERED
Jun 16, 2023 NWAP